Brian Dulisse

616 total citations
18 papers, 463 citations indexed

About

Brian Dulisse is a scholar working on Epidemiology, Infectious Diseases and Safety, Risk, Reliability and Quality. According to data from OpenAlex, Brian Dulisse has authored 18 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Safety, Risk, Reliability and Quality. Recurrent topics in Brian Dulisse's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Traffic and Road Safety (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Brian Dulisse is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Traffic and Road Safety (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Brian Dulisse collaborates with scholars based in United States, South Africa and Australia. Brian Dulisse's co-authors include Jerry Cromwell, Joel Charrow, Bryan M. Johnstone, E.T. Edgell, Dennis A. Revicki, Scott W. Andersen, Richard Barron, Kenneth J. Rothman, Julie Gayle and Jason C. Legg and has published in prestigious journals such as Blood, PLoS ONE and Health Affairs.

In The Last Decade

Brian Dulisse

18 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Dulisse United States 10 96 92 91 76 73 18 463
Shuli Qu China 11 50 0.5× 64 0.7× 13 0.1× 28 0.4× 22 0.3× 31 403
Javier Almazán‐Isla Spain 13 21 0.2× 89 1.0× 51 0.6× 12 0.2× 9 0.1× 28 382
P McCarron United Kingdom 10 25 0.3× 46 0.5× 13 0.1× 5 0.1× 42 0.6× 15 319
Seyed Mehdi Ahmadi Iran 11 69 0.7× 23 0.3× 20 0.2× 56 0.7× 18 0.2× 25 330
Qiming Feng China 9 13 0.1× 35 0.4× 6 0.1× 78 1.0× 11 0.2× 14 410
Richard Crilly Canada 12 49 0.5× 61 0.7× 56 0.6× 1 0.0× 60 0.8× 21 493
Sharon Hrynkow United States 8 40 0.4× 53 0.6× 11 0.1× 51 0.7× 5 0.1× 10 474
Claire Nguyen United States 4 18 0.2× 45 0.5× 18 0.2× 9 0.1× 23 0.3× 6 330
Cindy Y. Chang United States 9 34 0.4× 69 0.8× 48 0.5× 5 0.1× 90 1.2× 18 420
Sam George United Kingdom 12 48 0.5× 36 0.4× 41 0.5× 3 0.0× 10 0.1× 41 495

Countries citing papers authored by Brian Dulisse

Since Specialization
Citations

This map shows the geographic impact of Brian Dulisse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Dulisse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Dulisse more than expected).

Fields of papers citing papers by Brian Dulisse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Dulisse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Dulisse. The network helps show where Brian Dulisse may publish in the future.

Co-authorship network of co-authors of Brian Dulisse

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Dulisse. A scholar is included among the top collaborators of Brian Dulisse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Dulisse. Brian Dulisse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nunes, Marta C., Martin Hale, Sana Mahtab, et al.. (2022). Clinical characteristics and histopathology of COVID-19 related deaths in South African adults. PLoS ONE. 17(1). e0262179–e0262179. 8 indexed citations
2.
Nunes, Marta C., Martin Hale, Sana Mahtab, et al.. (2021). Clinical Characteristics and Histopathology of COVID-19 Related Deaths in South African Adults. SSRN Electronic Journal. 1 indexed citations
3.
Dulisse, Brian, Xiaoyan Li, Julie Gayle, et al.. (2013). A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia. Journal of Medical Economics. 16(6). 720–735. 70 indexed citations
4.
Dulisse, Brian, Xiaoyan Li, Julie Gayle, et al.. (2012). Clinical and Economic Burden During Hospitalizations Among Cancer Patients with Febrile Neutropenia: Evidence From U.S. Hospitals, 2007–2010. Blood. 120(21). 239–239. 2 indexed citations
5.
Dulisse, Brian & Jerry Cromwell. (2010). No Harm Found When Nurse Anesthetists Work Without Supervision By Physicians. Health Affairs. 29(8). 1469–1475. 59 indexed citations
6.
Charrow, Joel, et al.. (2007). The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease. Clinical Genetics. 71(3). 205–211. 97 indexed citations
7.
Valgimigli, Marco, Nicole Mittmann, David J. Cohen, et al.. (2007). A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. International Journal of Cardiology. 128(1). 53–61. 1 indexed citations
8.
Grabowski, Gregory A., Joel Charrow, Neal J. Weinreb, & Brian Dulisse. (2004). Enzyme Replacement Therapy in Gaucher Disease: Beneficial Effects on Bone Crisis and Bone Pain.. Blood. 104(11). 3825–3825. 1 indexed citations
9.
Edgell, E.T., et al.. (2000). Olanzapine versus Risperidone. PharmacoEconomics. 18(6). 567–579. 57 indexed citations
10.
Rittenhouse, B, et al.. (2000). An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.. PubMed. 6(3). 381–9. 15 indexed citations
11.
Edgell, E.T., Bryan M. Johnstone, Brian Dulisse, et al.. (2000). P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia. European Psychiatry. 15(S2). 408s–408s. 3 indexed citations
12.
Rittenhouse, B, Brian Dulisse, & Aaron A. Stinnett. (1999). At what price significance? The effect of price estimates on statistical inference in economic evaluation. Health Economics. 8(3). 213–219. 9 indexed citations
13.
Dulisse, Brian, et al.. (1999). WTG1: APPLES AND APPLES, APPLES AND ORANGES: THE USE AND ABUSE OF AVERAGE DAILY DOSE IN PHARMACOECONOMIC RESEARCH. Value in Health. 2(3). 227–228. 3 indexed citations
14.
Tunis, Sandra L., et al.. (1999). Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia.. PubMed. 60 Suppl 19. 38–45; discussion 46. 34 indexed citations
15.
Dulisse, Brian, et al.. (1999). ID4: A COST ANALYSIS OF LEVOFLOXACIN VERSUS CEFTRIAXONE IN ADULT INPATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Value in Health. 2(3). 135–135. 1 indexed citations
16.
Dulisse, Brian. (1997). Methodological issues in testing the hypothesis of risk compensation. Accident Analysis & Prevention. 29(3). 285–292. 30 indexed citations
17.
Dulisse, Brian. (1997). Driver age and traffic citations resulting from motor vehicle collisions. Accident Analysis & Prevention. 29(6). 779–783. 11 indexed citations
18.
Dulisse, Brian. (1997). Older drivers and risk to other road users. Accident Analysis & Prevention. 29(5). 573–582. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026